Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Gill

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonistsSue Cramp, Hazel J Dyke, Christopher Higgs, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitorsSteve Price, Walter Bordogna, Ruth Braganza, et al.
Journal of Medicinal Chemistry|May 20, 2015
Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1Lewis Gazzard, Karen Williams, Huifen Chen, et al.
Journal of Medicinal Chemistry|July 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast CancerJun Liang, Jason R Zbieg, Robert A Blake, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|March 20, 2010
Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonistsSue Cramp, Hazel J Dyke, Christopher Higgs, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitorsSteve Price, Walter Bordogna, Ruth Braganza, et al.
Journal of Medicinal Chemistry|May 20, 2015
Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1Lewis Gazzard, Karen Williams, Huifen Chen, et al.
Journal of Medicinal Chemistry|July 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast CancerJun Liang, Jason R Zbieg, Robert A Blake, et al.
Pageof 2